Variations in the Costs of Pharmacological Treatments According to Exposure to Smoking: A Case Study in Cardiovascular Patients

 

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون: Vanina Ripari, Nadia, Eugenia Elorza, María, Silvana Moscoso, Nebel, Elena Vega, María
التنسيق: artículo original
الحالة:Versión publicada
تاريخ النشر:2011
الوصف:Several authors have demonstrated an association between the exposure to certain risk factors and the increase in costs of drug treatments for cardiovascular diseases. The present study analyses the pharmacological treatment costs of patients at a Coronary Care unit of dr. Jose Penna Hospital in the city of Bahia Blanca (Argentina) between March 2008 and May 2010. We analyze the daily middle cost variation of pharmacological treatments for ischemic cardiopathy patients with (or without)smoking habits. It has been observed that the cardiopathy isquemic patients with smoking habits face an increased cost associated with/due to higher direct costs in pharmacological treatments than those who were not exposed to smoking. At the same time, the estimated costs for each group of patients show variability depending on being estimated to maximum or minimum prices, as a result of the wide dispersion of prices seen in the pharmaceutical market.
البلد:Portal de Revistas UCR
المؤسسة:Universidad de Costa Rica
Repositorio:Portal de Revistas UCR
اللغة:Español
OAI Identifier:oai:portal.revistas.ucr.ac.cr:article/6940
الوصول للمادة أونلاين:https://revistas.ucr.ac.cr/index.php/reconomicas/article/view/6940
كلمة مفتاحية:COSTOS DE TRATAMIENTOS FARMACOLÓGICOS
CARDIOPATÍA ISQUÉMICA
HÁBITO TABÁQUICO
PHARMACOLOGICAL TREATMENT COSTS
ISCHEMIC CARDIOPATHY
SMOKING HABITS